Advertorial, B. Advertorial: EMA REAFFIRMS POSITIVE BENEFIT-RISK BALANCE OF BAYER’S XARELTO® FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION. SAHJ 2017, 13, 42-43.